Cargando…
Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
BACKGROUND: Hypertension is commonly reported in multiple myeloma (MM) patients and may be associated with older age, disease-related complications and consequences of MM treatments. This study evaluated the incidence rates of and risk factors for hypertension and malignant hypertension in newly-tre...
Autores principales: | Chari, Ajai, Mezzi, Khalid, Zhu, Shao, Werther, Winifred, Felici, Diana, Lyon, Alexander R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120425/ https://www.ncbi.nlm.nih.gov/pubmed/27876016 http://dx.doi.org/10.1186/s12885-016-2955-0 |
Ejemplares similares
-
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
por: Shah, Nina, et al.
Publicado: (2020) -
The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016) -
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019) -
Development and Validation of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data
por: Princic, Nicole, et al.
Publicado: (2016) -
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)